References
- Allon, M., J. Daugirdas, T. A. Depner, T. Greene, D. Ornt, and S. J. Schwab, for the HEMO Study Group. 2006. Effect of change in vascular access on patient mortality in hemodialysis patients. American Journal of Kidney Diseases 47 (3):469–77. doi:10.1053/j.ajkd.2005.11.023.
- Astor, B. C., J. A. Eustace, N. R. Powe, M. J. Klag, N. E. Fink, and J. Coresh, for the CHOICE Study Group. 2005. Type of vascular access and survival among incident hemodialysis patients: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Journal of the American Society of Nephrology: JASN 16 (5):1449–55. doi:10.1681/ASN.2004090748.
- Bradbury, B. D., F. Chen, A. Furniss, R. L. Pisoni, M. Keen, D. Mapes, and M. Krishnan. 2009. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality. American Journal of Kidney Diseases 53 (5):804–14. doi:10.1053/j.ajkd.2008.11.031.
- Branson, M., and J. Whitehead. 2002. Estimating a treatment effect in survival studies in which patients switch treatment. Statistics in Medicine 21 (17):2449–63.
- Hans, B. N., and S. B. Mortensen 2016. ucminf: General-Purpose Unconstrained Non-Linear Optimization. R package version 1.1-4. https://CRAN.R-project.org/package=ucminf
- Hastie, T., R. Tibshirani, and J. H. Friedman. 2001. The elements of statistical learning: Data mining, inference, and prediction. New York: Springer.
- Lacson, E. Jr., W. Wang, M. Lazarus, and R. M. Hakim. 2009. Change in vascular access and mortality in maintenance hemodialysis patients. American Journal of Kidney Diseases 54 (5):912–21. doi:10.1053/j.ajkd.2009.07.008.
- Lin, H., R. Zhang, W. Xu, and Y. Wang. 2017. Estimating time-varying treatment switching effects via local linear smoothing and quasi-likelihood. Computational Statistics and Data Analysis 110:50–63. doi:10.1016/j.csda.2016.12.012.
- Morden, J. P., P. C. Lambert, N. Latimer, K. R. Abrams, and A. J. Wailoo. 2011. Assessing methods for dealing with treatment switching in randomised controlled trials: A simulation study. BMC Medical Research Methodology 11:4. doi:10.1186/1471-2288-11-4.
- Robins, J. M., and A. A. Tsiatis. 1991. Correcting for non-compliance in randomized trials using rank preserving structural failure time model. Communications in Statistics - Theory and Methods 20 (8):2609–31. doi:10.1080/03610929108830654.
- Shao, J., and M. Chang, and S. C. Chow. 2005. Statistical inference for cancer trials with treatment switching. Statistics in Medicine 24 (12):1783–90.
- United States Renal Data System (USRDS). 2017. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
- Watkins, C., and X. Huang, and N. Latimer, and Y. Tang, and E. J. Wright. 2013. Adjusting overall survival for treatment switches: Commonly used methods and practical application. Pharmaceutical Statistics 6:348–57.
- White, I. R. 2006. Letter to the editor. Estimating a treatment effect in survival studies in which patients switch treatment. Statistics in Medicine 25 (9):1619–22. doi:10.1002/sim.2453.
- Wystrychowski, G., T. M. Kitzler, S. Thijssen, L. Usvyat, P. Kotanko, and N. W. Levin. 2009. Impact of switch of vascular access type on key clinical and laboratory parameters in chronic haemodialysis patients. Nephrology Dialysis Transplantation 24 (7):2194–200. doi:10.1093/ndt/gfp052.